New Appointment Extends Freeman Technology’s Applications Team
News Apr 22, 2013
Educated to PhD level, Doug has a background in chemistry and considerable experience in supporting the use of high precision scientific instrumentation. He is based at Freeman Technology’s headquarters in the UK and will be involved in supporting users of the FT4 Powder Rheometer® right through from initial installation and training to ongoing education and applications support.
Welcoming Doug to the team, Managing Director Tim Freeman said: “FT4 users around the world know they can call on the expertise and experience both of our representatives on the ground and the team working at our UK headquarters, where we continue to invest strongly in our R&D and applications support. The FT4 Powder Rheometer is now used in a diverse range of industrial situations and we are growing our teams to ensure that we continue to develop the customer support excellence for which we are known.”
Doug Millington-Smith will be involved in installing Instruments at user sites and providing initial user training. Users will then be able to turn to him for remote advice and continued support in all areas including analysis and data interpretation if needed.
“The fact that Freeman Technology demonstrates the potential of its products through meaningful research makes it a very attractive company to work for,” said Doug. “I am delighted to now be part of such a successful team and am enjoying helping people across many different areas of powder characterization to make the most of their experience with our instruments.”
The days - or even weeks - spent waiting for the results of a cancer-screening test can feel like an eternity. Especially when early diagnosis and quick action are tied to better outcomes. Now, a new technique to analyze proteins expressed on cancer cells shows promise in more rapidly detecting these cell types.READ MORE
Scientists working in a range of disciplines joined forces to identify a new approach to combat African sleeping sickness. Their research revealed a promising strategy to develop a suitable agent. This novel concept could also be employed in the future rational design of drugs for the treatment of other diseases.READ MORE
15th International Conference on Surgical Pathology and Cancer Diagnosis
Apr 15 - Apr 16, 2019